Low-intensity warfarin therapy was found to be as effective as standard-intensity I warfarin in lowering the risk for thromboembolism in older patients with nonvalvular atrial fibrillation.
Expert consensus decision pathway for anticoagulant and antiplatelet use in patients with atherosclerotic cardiovascular disease or in those with atrial fibrillation or venous thromboembolism undergoing percutaneous coronary intervention.
A team of investigators examined the effect of a history of venous thromboembolism on recurrence of thrombosis in patients with cancer.
Patients with thromboembolism have increased pooled odds of mortality compared to those without.
Patients with thrombophilia demonstrate an elevated risk for venous thromboembolism after undergoing orthopedic surgery.
The use of Ikari-curve left guiding catheters during balloon pulmonary angioplasty was found to allow access to branches not accessible with conventional guiding catheters.
Pulmonary vein sign was found to be easy to detect and to have higher sensitivity and specificity in chronic thromboembolic pulmonary hypertension compared with acute pulmonary embolism.
The risk for venous thromboembolism is steadily increasing among patients with cancer compared with the general population.
The authors of a letter to the editor recommend caution when altering oral anticoagulants prescriptions for patients with postoperative atrial fibrillation.
Genetic variants in some patients with inflammatory bowel disease (IBD) are associated with a significantly increased risk for developing thromboembolic disease.
